Variability of Immune Response to CoronaVac in the Indonesian Population: A Retrospective Cohort Study in Bantaeng, South Sulawesi,Indonesia
Journal of Health Research · 04.08.2025 · 39 (4)
DOI: 10.56808/2586-940x.1152 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Health Research, online erschienen am 04.08.2025. Verfasst von Sitti Musafirah Arif und 8 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Background
The COVID-19 vaccine, including CoronaVac, is crucial in reducing severe infections and mortality due to COVID-19. However, variability in antibody responses across different populations remains a subject of investigation. This study aimed to evaluate the impact of age and BMI on Immunoglobulin G (IgG) antibody levels three months post-CoronaVac vaccination in a healthy Indonesian cohort.
Methods
A retrospective cohort study was conducted on 299 healthy individuals aged 18–70 in Bantaeng, South Sulawesi, Indonesia. IgG levels against the SARS-CoV-2 spike protein receptor-binding domain (RBD) were measured using enzyme-linked immunosorbent assay (ELISA). Blood samples were collected about 90 ± 7 days after the second dose of the vaccine. Baseline IgG levels before vaccination were not measured. However, all participants were confirmed to be immunologically naïve based on the absence of COVID-19 symptoms or infection history. The associations between IgG levels, age, and BMI were analyzed using non-parametric statistical tests.
Results
Detectable levels of IgG antibodies were observed three months post-vaccination, with a mean concentration of 4.56 mg/dL. Although the youngest age group (18–35 years) and overweight participants exhibited the highest IgG levels, no significant correlations were observed between IgG levels and age (ρ = –0.042, p = 0.7) or BMI (ρ = 0.043, p = 0.5).
Conclusion
IgG responses to CoronaVac were consistent across age and BMI groups, despite expected variation. These findings support its broad use in Indonesia’s diverse population and national vaccination programs. Keywords: Humoral response, COVID-19 vaccines, Inactivated vaccines, Indonesia
Zitieren
APA
Arif, S. M., Ibrahim, J., Winarno, A. P., Anna, A. N., Sompa, A. W., Achmad, A. F. S., Nurdiana, N., Zulkifli, Z., & Ashari, I. (2025). Variability of Immune Response to CoronaVac in the Indonesian Population: A Retrospective Cohort Study in Bantaeng, South Sulawesi,Indonesia. Journal of Health Research, 39(4). https://doi.org/10.56808/2586-940x.1152
Vancouver
Arif SM, Ibrahim J, Winarno AP, Anna AN, Sompa AW, Achmad AFS, et al. Variability of Immune Response to CoronaVac in the Indonesian Population: A Retrospective Cohort Study in Bantaeng, South Sulawesi,Indonesia. Journal of Health Research. 2025;39(4). doi:10.56808/2586-940x.1152
BibTeX
@article{Arif2025,
author = {Arif, Sitti Musafirah and Ibrahim, Juliani and Winarno, Antariksa P. and Anna, Andi Nur and Sompa, Andi Weri and Achmad, Ami Febriza S. and Nurdiana, Nurdiana and Zulkifli, Zulkifli and Ashari, Irwan},
title = {Variability of Immune Response to CoronaVac in the Indonesian Population: A Retrospective Cohort Study in Bantaeng, South Sulawesi,Indonesia},
journal = {Journal of Health Research},
year = {2025},
volume = {39},
number = {4},
doi = {10.56808/2586-940x.1152}
}
EUVIMED